Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
fig.S4.a
Zhao Y et al. (2016)
|
Xla Wt + efhc1 MO
NF18 (in situ hybridization)
|
|
|
|
fig.S5.e
Macrì S et al. (2016)
|
Xla Wt + hmga2 MO
NF17 (in situ hybridization)
|
|
|
|
Fig.6.a,b
Wylie LA et al. (2015)
|
Xla Wt + ccna2 + cdk2
NF18-19 (in situ hybridization)
|
|
|
|
Fig.3.a,b
Wylie LA et al. (2015)
|
Xla Wt + cdknx MO
NF18-19 (in situ hybridization)
|
|
|
|
Fig.6.a,b
Wylie LA et al. (2015)
|
Xla Wt + Mmu.ascl1
NF18-19 (in situ hybridization)
|
|
|
|
Fig.7.a,b
Wylie LA et al. (2015)
|
Xla Wt + Mmu.ascl1
NF18-19 (in situ hybridization)
|
|
|
|
Fig.6.a,b
Wylie LA et al. (2015)
|
Xla Wt + Mmu.ascl1 + ccna2 + cdk2
NF18-19 (in situ hybridization)
|
|
|
|
Fig.7.a,b
Wylie LA et al. (2015)
|
Xla Wt + Mmu.ascl1 + mycn
NF18-19 (in situ hybridization)
|
|
|
|
Fig.6.a,b
Wylie LA et al. (2015)
|
Xla Wt + Mmu.ascl1S62A,S88A,S185A,S189A,S202A,S218A + ccna2 + cdk2
NF18-19 (in situ hybridization)
|
|
|
|
Fig.7.a,b
Wylie LA et al. (2015)
|
Xla Wt + mycn
NF18-19 (in situ hybridization)
|
|
|